One step forward, one step sideways? Expanding research capacity for neglected diseases-Reference-Cited by-同舟云学术

One step forward, one step sideways? Expanding research capacity for neglected diseases

Published:2010-07-14 Issue:1 Volume:10 Page:
ISSN:1472-698X
Container-title:BMC International Health and Human Rights
language:en
Short-container-title:BMC Int Health Hum Rights

Author:

Lexchin Joel

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/article/10.1186/1472-698X-10-20/fulltext.html

Reference51 articles.

1. Finkelstein S, Temin P: Reasonable Rx: solving the drug price crisis. 2008, Upper Saddle River: FT Press

2. Jack A: Novartis chief in warning on cheap drugs. Financial Times. 2006, 8-

3. Chirac P, Torreele E: Global framework on essential health R&D. Lancet. 2006, 367: 1560-1561. 10.1016/S0140-6736(06)68672-8.

4. Drugs for Neglected Diseases Working Group, Campaign for Access to Essential Medicines: Fatal imbalance: the crisis in research and development for drugs for neglected diseases. 2001, Geneva: Médecins Sans Frontières Access to Essential Medicines Campaign and Drugs for Neglected Diseases Working Group

5. Moran M, Ropars AL, Guzman J, Diaz J, Garrision C: The new landscape of neglected disease drug development. 2005, London: Wellcome Trust

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on the narrowing and clustering of research trajectories: an epistemic threat to medical progress?;Science and Public Policy;2022-12-14

2. Strategies for developing sustainable health research capacity in low and middle-income countries: a prospective, qualitative study investigating the barriers and enablers to locally led clinical trial conduct in Ethiopia, Cameroon and Sri Lanka;BMJ Open;2017-10

3. Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature;Health Policy;2017-07

4. Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature;BMJ Open;2017-01

5. Multi-Target Drugs for Neglected Diseases;Current Pharmaceutical Design;2016-05-30